Enamine US Inc.

South Brunswick Township, NJ

UEI
MA1RWC9F3MH5
CAGE
8PGH1
Primary NAICS
424690 Other Chemical and Allied Products Merchant Wholesalers
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1 Distribution Way, Monmouth Junction, NJ 08852, USA
Website
enamine.net
Founded
1991
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Materials
  2. Chemicals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $40,420
FY2025 $222,576
FY2024 $35,919
FY2023 $57,736

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $40,420

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Enamine US Inc., a for-profit chemical research and pharmaceutical services company based in Monmouth Junction, New Jersey, delivers specialized laboratory testing services, chemical compound libraries, and small-molecule assay development to federal health research agencies as a prime contractor on purchase orders carrying no set-aside designations. The vendor operates exclusively as a prime (100% of recent awards) across a small, focused portfolio of twelve federal awards worth $502 thousand in combined potential value, with all dollars obligated.

Enamine's customer base concentrates entirely within the Department of Health and Human Services. The National Institute on Alcohol Abuse and Alcoholism anchors the relationship with five awards worth $118 thousand combined potential value, followed by the National Institute on Drug Abuse (one award, $175 thousand), the National Center for Advancing Translational Sciences (two awards, $124 thousand), the National Institute of Child Health and Human Development (three awards, $63 thousand), and the CDC Pittsburgh office (one award, $22 thousand). The NIDA award, though single-order, carries the largest dollar value and represents the vendor's expansion into covalent small-molecule libraries. Activity distribution spans 2022 through 2026, with two to three awards per year and no significant growth trajectory.

Representative work includes a $175 thousand NIDA purchase order (September 2025) to supply 1,000 compounds from Sulfamoyl Fluorides and Cyanamides sets for the National Center for Advancing Translational Sciences' Covalent Screening Library expansion; a $40,420 NIAAA purchase order (September 2026) for Enamine chemical reagent assay development and ADME assay production for medicinal chemistry research at Monmouth Junction; a $24,189 NCATS purchase order (August 2022) for a 167-compound library sourced from virtual screening for COVID-19 research; and a $22,160 CDC Pittsburgh purchase order (March 2023) for RNA library services. The vendor also delivers pharmacokinetic studies in mice, single-cell RNA sequencing analysis, and in vitro ADME assays supporting NIAAA's alcohol abuse and translational science programs.

Enamine operates in Medical Laboratories (5 awards) and chemical product manufacturing and distribution (6 awards across All Other Miscellaneous Chemical Product and Preparation Manufacturing, All Other Basic Organic Chemical Manufacturing, and chemical merchant wholesaler categories), with services spanning reference laboratory testing, drugs and biologicals procurement, and diagnostic substances and reagents. One award reaches ultimate completion within the next twenty-four months ($40 thousand), representing modest recompete exposure. The vendor has no subcontract footprint and does not sit on government-wide vehicles or agency-wide IDIQs; all work flows through direct purchase orders to individual NIH institutes and CDC offices.

Quick answers

Is Enamine US Inc. registered in SAM.gov?

Enamine US Inc.'s SAM.gov registration expired on November 3, 2026.

What is Enamine US Inc.'s CAGE code?

Enamine US Inc.'s CAGE code is 8PGH1, and its Unique Entity ID (UEI) is MA1RWC9F3MH5.

How much has Enamine US Inc. received in federal contracts?

Federal contracts obligated $222,576 to Enamine US Inc. in fiscal year 2025 and $356,651 in fiscal years 2023 through 2027.

How does Enamine US Inc. rank among federal contractors?

Enamine US Inc. ranked #79 in NAICS 325998, #89 in PSC 6810 and #90 in NAICS 32599 in FY2025.

What is Enamine US Inc.'s most recent federal award?

Enamine US Inc.'s most recent federal contract award is Quotation date september 11, 2026 study code: BENA20260213AG 1 price quote attached (75N98026P01736), from Office of Logisitics and Acquisition Operations (NIH), on September 22, 2026.

On GovTribe

See Enamine US Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe